Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

NCT00031902 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
BIOLOGICAL: rituximab
DRUG: prednisolone
DRUG: vincristine sulfate

Sponsor

Lymphoma Trials Office